US Patent Issued to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY on May 12 for "Pharmaceutical composition for preventing or treating brain disease, comprising stem cell-derived exosome surface-modified with compound capable of binding to dopamine receptors or L-amino acid transporters" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,930, issued on May 12, was assigned to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (Suwon-si, South Korea).

"Pharmaceutical composition for preventing or treating brain disease, comprising stem cell-derived exosome surface-modified with compound capable of binding to dopamine receptors or L-amino acid transporters" was invented by Jae Hyung Park (Suwon-si, South Korea), Dong Gyu Jo (Suwon-si, South Korea), Sol Shin (Suwon-si, South Korea) and Jae Hoon Sul (Anyang-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for preventing or treating a brain disease, comprisin...